Regulatory landscape in brain development and disease.


Journal

Current opinion in genetics & development
ISSN: 1879-0380
Titre abrégé: Curr Opin Genet Dev
Pays: England
ID NLM: 9111375

Informations de publication

Date de publication:
12 2020
Historique:
received: 30 01 2020
revised: 06 04 2020
accepted: 01 05 2020
pubmed: 22 6 2020
medline: 2 7 2021
entrez: 22 6 2020
Statut: ppublish

Résumé

Although many regulatory elements in the non-coding genome are linked to brain development and disease, deciphering their function has been challenging due to the lack of a genomic toolbox. However, recent advances in high throughput sequencing techniques have allowed us to begin decoding its function, enhancing our understanding of the regulatory landscape that underpins human traits and brain disorders. Here, we review how the regulatory landscape of the human brain undergoes dynamic changes across neurodevelopment, different cell types, and human evolution. We then discuss how regulatory landscapes shed light onto the molecular basis of neuropsychiatric disorders and guide the development of specifically targeted molecular therapies. Finally, we offer some thoughts on how these discoveries might impact the direction of future studies.

Identifiants

pubmed: 32563855
pii: S0959-437X(20)30058-7
doi: 10.1016/j.gde.2020.05.007
pmc: PMC7746596
mid: NIHMS1595255
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-60

Subventions

Organisme : NIMH NIH HHS
ID : DP2 MH122403
Pays : United States
Organisme : NIMH NIH HHS
ID : R00 MH113823
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066871
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA051921
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Mol Cell. 2018 Sep 6;71(5):858-871.e8
pubmed: 30078726
Nat Neurosci. 2019 Jul;22(7):1182-1195
pubmed: 31209381
Cell Rep. 2020 Apr 7;31(1):107489
pubmed: 32268104
Nature. 2017 Feb 15;542(7641):348-351
pubmed: 28202961
Curr Opin Cell Biol. 2020 Jun;64:1-9
pubmed: 32036200
Cell. 2016 Oct 6;167(2):341-354.e12
pubmed: 27667684
Nat Genet. 2020 Jan;52(1):8-16
pubmed: 31925403
Nature. 2015 Feb 19;518(7539):365-9
pubmed: 25693568
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Nat Commun. 2018 Aug 7;9(1):3121
pubmed: 30087329
Schizophr Res. 2020 Mar;217:17-25
pubmed: 30894290
Nature. 2016 Jul 13;535(7612):367-75
pubmed: 27409810
Cell. 2013 Nov 21;155(5):1008-21
pubmed: 24267887
Nat Rev Genet. 2015 Aug;16(8):441-58
pubmed: 26149713
Cell. 2019 Oct 17;179(3):750-771.e22
pubmed: 31626773
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Neuron. 2019 Apr 3;102(1):143-158.e7
pubmed: 30770253
Nat Genet. 2018 Jun;50(6):825-833
pubmed: 29785013
Science. 1975 Apr 11;188(4184):107-16
pubmed: 1090005
Nat Commun. 2019 Jul 19;10(1):3222
pubmed: 31324783
Nat Neurosci. 2016 Mar;19(3):494-503
pubmed: 26807951
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Nat Neurosci. 2019 Mar;22(3):353-361
pubmed: 30692689
Nature. 2020 Feb;578(7793):142-148
pubmed: 31996853
Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Science. 2016 Jun 24;352(6293):1586-90
pubmed: 27339989
Cell. 2018 Sep 20;175(1):224-238.e15
pubmed: 30173918
Cell. 2019 Aug 8;178(4):850-866.e26
pubmed: 31398340
Annu Rev Cell Dev Biol. 2017 Oct 6;33:265-289
pubmed: 28783961
Cell. 2018 Jan 11;172(1-2):289-304.e18
pubmed: 29307494
Nat Biotechnol. 2011 Nov 20;29(12):1109-13
pubmed: 22101486
Cell. 2016 Nov 17;167(5):1385-1397.e11
pubmed: 27863250
Genome Res. 2018 Aug;28(8):1243-1252
pubmed: 29945882
Science. 2018 Dec 14;362(6420):
pubmed: 30545853
Nature. 2012 Apr 11;485(7398):381-5
pubmed: 22495304
Science. 2018 Dec 14;362(6420):
pubmed: 30545857
Nat Commun. 2019 Jun 3;10(1):2396
pubmed: 31160561
Cell. 2013 Aug 1;154(3):518-29
pubmed: 23911319
Science. 2017 Dec 8;358(6368):1318-1323
pubmed: 29217575
Nat Neurosci. 2020 Apr;23(4):583-593
pubmed: 32152537
Nature. 2019 Jun;570(7762):523-527
pubmed: 31168097
Science. 2018 Sep 28;361(6409):1380-1385
pubmed: 30166440
Cell. 2015 Sep 24;163(1):55-67
pubmed: 26406371
Sci Adv. 2018 Jan 24;4(1):eaao5961
pubmed: 29376123
Science. 2018 Dec 14;362(6420):
pubmed: 30545854
Nature. 2016 Oct 27;538(7626):523-527
pubmed: 27760116
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Science. 2018 Dec 14;362(6420):
pubmed: 30545851
Science. 2020 Jan 24;367(6476):
pubmed: 31974223
Nat Genet. 2019 Dec;51(12):1664-1669
pubmed: 31784727
Science. 2018 Dec 14;362(6420):
pubmed: 30545856
Nature. 2006 Sep 14;443(7108):167-72
pubmed: 16915236
Genome Biol. 2018 Nov 12;19(1):194
pubmed: 30419947
Cell Stem Cell. 2018 Aug 02;23(2):166-179
pubmed: 29754780
Science. 2015 Mar 6;347(6226):1155-9
pubmed: 25745175
Nat Genet. 2019 Oct;51(10):1442-1449
pubmed: 31501517
Nat Genet. 2018 Apr;50(4):621-629
pubmed: 29632380
Nat Neurosci. 2018 Aug;21(8):1126-1136
pubmed: 30038276
Cell. 2017 Oct 19;171(3):557-572.e24
pubmed: 29053968
Neuron. 2019 Sep 4;103(5):785-801.e8
pubmed: 31303374
Cell. 2020 Feb 6;180(3):568-584.e23
pubmed: 31981491
Science. 2019 May 3;364(6439):
pubmed: 31048460
Cell. 2016 Mar 10;164(6):1110-1121
pubmed: 26967279
Science. 2019 Nov 29;366(6469):1134-1139
pubmed: 31727856
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923

Auteurs

Keeley Spiess (K)

UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Hyejung Won (H)

UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: hyejung_won@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH